key: cord-0704909-eoezr3d3
authors: Sadeghi, Poorya; Sohrabi, Hessamaddin; Hejazi, Maryam; Jahanban-Esfahlan, Ali; Baradaran, Behzad; Tohidast, Maryam; Majidi, Mir Reza; Mokhtarzadeh, Ahad; Tavangar, Seyed Mohammad; Guardia, Miguel de la
title: Lateral flow assays (LFA) as an alternative medical diagnosis method for detection of virus species: The intertwine of nanotechnology with sensing strategies
date: 2021-10-21
journal: Trends Analyt Chem
DOI: 10.1016/j.trac.2021.116460
sha: 206e45a3c584c2aff9600dba91821c863d253422
doc_id: 704909
cord_uid: eoezr3d3

Viruses are responsible for multiple infections in humans that impose huge health burdens on individuals and populations worldwide. Therefore, numerous diagnostic methods and strategies have been developed for prevention, management, and decreasing the burden of viral diseases, each having its advantages and limitations. Viral infections are commonly detected using serological and nucleic acid-based methods. However, these conventional and clinical approaches have some limitations that can be resolved by implementing other detector devices. Therefore, the search for sensitive, selective, portable, and costless approaches as efficient alternative clinical methods for point of care testing (POCT) analysis has gained much attention in recent years. POCT is one of the ultimate goals in virus detection, and thus, the tests need to be rapid, specific, sensitive, accessible, and user-friendly. In this review, after a brief overview of viruses and their characteristics, the conventional viral detection methods, the clinical approaches, and their advantages and shortcomings are firstly explained. Then, LFA systems working principles, benefits, classification are discussed. Furthermore, the studies regarding designing and employing LFAs in diagnosing different types of viruses, especially SARS-CoV-2 as a main concern worldwide and innovations in the LFAs’ approaches and designs, are comprehensively discussed here. Furthermore, several strategies addressed in some studies for overcoming LFA limitations like low sensitivity are reviewed. Numerous techniques are adopted to increase sensitivity and perform quantitative detection. Employing several visualization methods, using different labeling reporters, integrating LFAs with other detection methods to benefit from both LFA and the integrated detection device advantages, and designing unique membranes to increase reagent reactivity, are some of the approaches that are highlighted.

J o u r n a l P r e -p r o o f

Viruses are infectious entities consisting of one kind of nucleic acid, either DNA or RNA, encapsulated by a protein shell, which their diameters vary from 16 nm to over 300 nm. They sometimes are wrapped in a lipid membrane in some species. Since viruses do not contain ribosomes or any other cell-like organelles, their only means of reproduction are infecting living cells and replicating using host cell ribosomes. Their nucleic acid consists of genes that code structural components, regulatory proteins, and enzymes [1, 2] . Viruses evolve through mutations which double-stranded (dsDNA) viruses' mutation rate is as high as 0-7 per nucleotide per year.

This rate is higher than in RNA viruses on the order of 3-10 per nucleotide per year [2] . The mutagenic nature of viruses sparked incidents like the sudden emergence of the most recent Covid- 19 and gave rise to variants of avian influenza that can be transmitted to humans [3] . Viruses can be also transmitted via aerosol and airborne droplets, fecal-oral, insect transmission, sexual transmission, blood-borne, and other unknown ways and can be entered human body through respiratory, gastrointestinal, and genital tracts, as well as skin, eye, placenta, transplants, and blood transfusion and they can exit the body through entering ways [4] . Currently, 224 virus species are known that can infect humans, every year, three to four new species are discovered, and there is a lot more to be found [5, 6] . Occurrences of emerging and re-emerging viral infections and deadly viral diseases have significantly affected human health. They can cause respiratory, intestinal, skin, single organ (e.g., liver, lung, heart, etc.), multi-organ, neurologic, hematologic, immunosuppressive diseases [7] . Furthermore, viruses can alter host cell's genetic material and cause benign and malignant tumors [4] . Due to the urgency and severity of viral infections, J o u r n a l P r e -p r o o f accurate, reliable, user-friendly, available, rapid, and low-cost detection methods are necessary [8] .

Established approaches such as virus isolation methods like virus culture, nucleic acid-based detection methods like Polymerase chain reaction (PCR), and serologic methods like enzymelinked immunosorbent assay (ELISA) are widely used in clinical settings. Although these methods are highly sensitive and specific, they require expensive equipment and expert operators and lack the rapidity of newer detection methods [9] . Biosensors are one the alternative methods to conventional methods. A biosensor is a diagnostic device consisting of an electrical transducer that transforms biological responses from a recognition receptor to an electrical signal detected, correlated, and demonstrated by an electrical detector [10, 11] . Biosensors can be classified by numerous approaches, considering their electrical transducer, their bio element, and the detected component as the categorization criterion [12, 13] . Biosensors, however, have some limitations (e.g., low sensitivity) that can be overcome using nanotechnology [14] [15] [16] .

Lateral flow assays (LFA) are the most recently used approaches for biosensing and quantifying numerous analytes, including different viruses [17] . The technical principle of LFAs was derived from the latex agglutination test. The first enzyme immunoassay was introduced in the 1960s, with several advantages like rapidity, ease of use, and long shelf life. The LFA principle was first popularized by the human pregnancy test that detected human chorionic gonadotropin in pregnant women urines, and since then, LFAs have been widely used in medicine and other areas like veterinary, agriculture, biowarfare, food, environmental health and safety [18] . LFAs application in medicine are highly versatile and can be used for diagnosis, prognosis, screening, monitoring, and surveillance. Unlike conventional methods, they can be used outside of high-tech laboratories and are applied in hospital wards, clinics, health centers, physicians' offices, and also can be used by patients themselves for self-diagnosis [17] . This review aims to discuss the recent developments of LFA devices in detection of different viral diseases. Various characteristics of LFA detection J o u r n a l P r e -p r o o f approaches used for determination of various kinds of viruses are comprehensively discussed.

Additionally, current challenges and problems as well as different strategies considered in the recently introduced LFA-based portable systems for eliminating shortcomings and enhancing their efficiency for the effective determination of different kinds of viral species are highlighted in this review. [19, 20] . Despite being one of the oldest detection techniques, serological methods are still widely used in clinical recognitions owning to their high sensitivity, specificity, ease of use and cheapness. Based on the manifestation of anti-viral immunoglobulin (Ig) using virus antigen (Ag) in the sample, serological approaches can be employed to diagnose and monitor viral diseases [21] . ELISA is one of the serological methods that use enzyme-labeled antibodies (Abs) to detect viral Ags, making it feasible for detecting Abs in large sample groups [22] . The ELISA method is initiated by coating the plate with specific J o u r n a l P r e -p r o o f antigens or antibodies that detect the desired analyte, and then the plate is then washed to remove any unbound substrates. Then animal proteins like ovalbumin, aprotinin, etc., are used to block unbound spots in the container. After another washing step, an enzyme-linked detection antibody is added that binds to the primary antibody. Another washing step is performed, then a substrate/chromophore is added, producing a color detected and measured by the reader to quantify the detected analyte [23] . ELISA method is sensitive, quantitative, and relatively low-cost for [20, 35, 36] . Due to such limitations in the current approaches, a rapid, specific, sensitive, user-friendly, and affordable diagnostic method for virus detection is required.

The LFA-based devices may be a good substitute for POCT application in virus detection. LFA is a paper-based biosensor device that can rapidly detect various analytes (e.g., proteins, haptens, nucleic acids, and amplicons) from multiple types of samples (e.g., urine, saliva, sweat, serum, plasma, nasopharyngeal swabs, and stool) within 5-30 minutes [37] [38] [39] . The use of capillary forces in the nitrocellulose (NC) membrane speeds up and facilitates the efficiency of the assay.

Furthermore, membrane fiber arrangements can filter out any unwanted analyte in the sample [40] .

These tests can be applied in the clinical setting due to their user-friendliness and cheap manufacturing cost and are helpful for onsite decision-making [41] . In addition to these, LFAs have are stable in various environmental conditions and have a long shelf-life, require small sample volume, do not require pre-preparation for fluid samples or washing steps. LFAs mostly require little to no energy, but can be integrated with electronics, have a high potential for commercialization, and be used in various approaches [42] . For these benefits, LFAs are suitable J o u r n a l P r e -p r o o f devices for detecting viruses in any sample for clinical practice. LFAs have attracted considerable attention in recent years due to being rapid, cost-effective, user-friendly, and portable [43] . Due to their portability, LFAs can be used in deprived areas, and due to their user-friendliness, they can be performed without expert personnel [38] . LFAs can be classified into lateral flow immunoassay (LFIA), which uses antibodies as recognition elements, and nucleic acid lateral immunoassay (NAFLA), which detects amplicons produced during other nucleic-based amplification devices like PCR. LFIA [38] . Based on their detection approaches, the LFIAs can further be classified into sandwich type and competitive type [44] . As shown in Figure 1A , a conventional sandwich LFA strip typically includes some pads such as a sample application pad, conjugate pad as well as NC membrane, and an absorbent pad. Upon introducing sample to the application pad, it will move to the conjugate pad. The conjugate pad contains labeling reporters conjugated to detector probes In the sandwich format, the analyte binds to both detector probe and capture probe, therefore it is suitable for large molecules. The competitive format is more suitable for small molecule like haptens. Competitive format itself can be divided into two setups. In the first setup, both analyte and the molecule that is conjugated to labeling reporter have a high affinity to bind with Abs on the TL, therefore the analyte compete with the reporter probe. In the second setup, the analyte J o u r n a l P r e -p r o o f attaches to the reporter probe, therefore blocks it from attaching to the Abs on the TL. In both formats, with higher concentration of analyte in the sample, the signal intensity on the TL decreases [44] . [71] Catalytic hairpin assembly (CHA) as an application reaction was utilized by Zou and coworkers for designing an isothermal and nonenzymatic signal amplification system coupled with a lateral flow immunoassay (LFIA) strip-based device for signal amplification and sensitive RNA detection of SARS-CoV-2 that takes 90 minutes for completing diagnostic process. In this study, the hairpins DNA probes H1 and H2 were manufactured and were conjugated with biotin and digoxigenin were tested by Genemedi and Genscript half-strips for calculating LOD. The LOD of Geneemedi and Genscript was estimated to be 0.65 and 3.03 ng/mL, respectively [78] . Furthermore, Baker and coworkers designed a LFA detection device using multivalent gold nanoparticles (Au NPs) stabilized in polymer and containing the derivatives of sialic acid with binding ability to SARS-COV-2's spike proteins. In this study, Au NPs were identified as the best target ligand and reporting J o u r n a l P r e -p r o o f label. 2,3′-sialyl lactose-bovine serum albumin (BSA) was used as the negative control, for blocking NPs binding ( Figure 1B ). The positive control was the immobilized spike protein of recombinant S1 subunit (SARS-COV-2, S1). The device was evaluated and showed that it could detect a concentration of 5 μg of virus-like particles in less than 30 minutes [45] . Huang and coworkers developed an IgM Ab-based LFA for detecting Sars-Cov-2 onsite. They manufactured a colloidal Au NP strip by coating the SARS-Cov-2 nucleoprotein on the membrane to form the sample capture and conjugated anti-human IgM with Au NPs to produce the detecting reporter ( Figure 1C ). The detection device was evaluated and had a sensitivity of 100% and a specificity of 93.3% [46] .

In an investigation, for amplifying RNA in the specimens infected by virus, Zhang and coworkers integrated direct RT-LAMP, with LFA to interpret the amplification process by optical means to detect Sars-Cov-2 in less than 40 minutes. In this study, the anti-fluorescein isothiocyanate (anti-FITC) Ab was used at the TL to act as a CP, and immobilized biotin was used at the CL. STVcoated particles were used as the labeling reporters. LAMP primers were designed to bind and amplify open reading frame (ORF1ab) and nucleoprotein genes. The evaluations demonstrated that this method has no cross-reaction with other viruses and has an accuracy of 100% in detecting the SARS-Cov-2 virus [47] . Additionally, Chen and coworkers developed a LFA anti-SARS-CoV-2

IgG detection device utilizing lanthanide-doped polystyrene NPs (LDP NPs). In this study, at the TL, the CP was recombinant nucleocapsid phosphoprotein of SARS-CoV-2 and at the CL, goat anti-rabbit (GAR) IgG was used ( Figure 1D ). The used detector probe was prepared by functionalizing LDP NPs using rabbit IgG and mouse anti-human (MAH) IgG Ab and the whole detection process completed only within 10 minutes. The device's performance was compared with RT-PCR and 7 positive cases were consistent with LFA's results. One of the samples considered J o u r n a l P r e -p r o o f negative with RT-PCR but tested positive with LFA was determined to be SARS-CoV-2 IgG positive, suggesting LFA's higher sensitivity compared with RT-PCR [79] .

In a research conducted by Daoud and coworkers, they used two commercially available LFA kits, including the Raybiotech and the Healgen Scientific for SARS-CoV-2 IgM/IgG, and comparatively evaluated the combination of kits and each of them alone. It was reported that the sensitivity of IgM varied between 58.9 and 66.2% and 87.7% for each kit and the combination form of kits, respectively. Still, the IgG sensitivity didn't change while using the combination strategy. Both kits showed high specificity (99.2 and 100%) [80] . Moreover, in another investigation, Azmi and coworkers developed a CRISPR-Cas13a based SARS-CoV-2 RNA detection device coupled with LFA readout integrated with a smartphone application for user-friendliness. The target RNA was amplified using CRISPR-Cas13a and RT-RPA and the final products were added to LFA for visualization. The intensity of the TL was interpreted using Fiji image J software to quantitatively detect amplified RNAs. The device showed a 98% agreement with RT-qPCR results [81] .

An LFIA diagnostic test named Chinese academy of science test (CAST) was also introduced by Villarreal [86] . And also, Xiong and coworkers developed a J o u r n a l P r e -p r o o f Figure 1 : A conventional LFA structure (A). Adapted by permission from Ref. [88] . A design concept for LFA, and the synthesis procedure of Au NPs (B). Adapted by permission form Ref. [45] . The Au NPs LF strip's operating principle and specificity of AuNP-LF strips for SARCS-CoV-2 (C). Adapted by permission from Ref. [46] Structure of a LNP-based LFA applied for SARCS-CoV-2 detection (D). Adapted by permission from Ref. [79] . Schematic depiction of a LFA with Au NPs coated by spike protein from SARS-CoV-2 on the wicking membrane (E). Adapted by permission from Ref. [85] .

Influenza viruses belong to the Orthomyxoviridae and cause respiratory infections. They can be transmitted by aerosol droplets from person to person or be zoonotic. Influenza causes multiple symptoms like high-grade fever, myalgia, headache, and malaise [89] . Influenza can be diagnosed via serology, Ag detection, nucleic-acid-based detection, and viral culture, RT-PCR being considered the gold standard [90, 91] . In the following, various LFA-based sensing platforms regarding Influenza determination are discussed. Kawasaki Evaluating this device revealed LOD of 102 and 103.5 EID50/mL for LPAI H5N2 and HPAI H5N6, respectively. This LFA's sensitivity is 10-fold higher than commercial LFAs and unlike them, the detection process isn't disrupted by the opacity and brown color of stool samples [54] .

For detecting the H5N2 Influenza virus, Kim and coworkers employed a pair of aptamers to develop an LFA. In this study, systematic evolution of ligand by exponential enrichment (SELEX) and graphene-oxide (GO) were used and an assay based on the fluorescence resonance energy transfer (FRET) mechanism and GO (GO-FRET) were utilized to manufacture virus particlespecific aptamers with capability to bind different parts of virus particles at the same time. Au NPs were used as signaling labels and were conjugated to JH4APT. J3APT was used at the TL as a CP, and poly-A sequence was immobilized at the CL as the COPs. Upon interpreting by ImageJ J o u r n a l P r e -p r o o f program and after evaluating the results, the LOD being 1.27 × 10 5 and 2.09 × 10 5 EID50/mL was determined for buffer and the duck's feces, respectively [93] . Figure 3A ). This LFA was evaluated and demonstrated a LOD of 5×10 2 pfu, which is suitable for clinical application [55] .

J o u r n a l P r e -p r o o f These studies showed that LFAs have a satisfactory performance in detecting the influenza virus.

Using multiplex LFAs is a great way to diagnose common subtypes of influenza and avoid under treatment. Different approaches like integrating with other detection devices and alternate reading devices were used to improve LFAs performance.

HIV is a member of the Retroviridae family that attacks the host's CD4 + lymphocytes, leading to acquired immunodeficiency syndrome (AIDS) [102] . A third of the people infected with HIV never notice it until it has advanced to a more advanced state and remain an asymptomatic career, which increases the burden of the disease [103] . Therefore, HIV infection should be diagnosed early and needs rapid and cheap POCT for diagnosis and surveillance [104] . Accordingly, Tang and a specificity of 98.7% [110] .

Another investigation performed by Zhang and coworkers, demonstrated an LFA by fixing cotton threads onto a membrane to detect HIV. In this study, the hydrophilicity of cotton threads was decreased using Hexadecyltrimethoxysilane (HDTMS) and was fixed paper to form the LFA's membrane. Cotton-embedded papers delay fluid flow and therefore increase the reagents'

interaction and, in turn, the LFA's sensitivity. Au NPs were conjugated with detector probes, and test probes and COPs were immobilized at the TL and CL. Employing cotton threads increases LFA's sensitivity four-fold compared with conventional LFAs [98] . J o u r n a l P r e -p r o o f

HBV as a leading causes of liver disease in the family Hepadnaviridae can be transmitted sexually or via blood transfer . HBV can cause both acute and chronic hepatitis and can lead to liver cancer [114, 115] . There are several serum markers for HBV, including HB Abs, HB Ags, HBc Ab, and

HBe, each of which is found during different phases of HBV replication [116] . HBV infection can be asymptomatic but can still be transferred, and early diagnosis should be applied using POCTs [117] . By using QDs nanobeads, a multiplex integrated fluorescent LFA to detect infectious pathogens including HIV, HCV, HBV, and Treponema pallidum (TP) was developed Rong and coworkers. In this study, multicolor QDs nanobeads were used as labeling reporters to increase sensitivity and specificity. Different Ags for HIV-1/2, HCV, HBV, and HBs were used both as capture and detection probes. The GAM IgG Ab was used at the CL to detect and capture remaining QD nanobeads. An optical receiver and an Android app were used to receive and interpret fluorescent signals emitted from QD nanobeads at the TL to diagnose and quantify the captured pathogen. This LFA was evaluated, and pathogen detection sensitivities varied between 88.33-93.42%, and specificities were between 87.67-93.15% [60] .

In another investigation, Srsomwat developed an automated electrochemical LFA (eLFA) to detect HBV quantitatively. In this study, pyrrolidinyl peptide nucleic acid (acpcPNA) as an immobilized detector was used at the TL. The used membrane in this device had a unique design, allowing the tested serum to go through a non-delayed channel and the HBV DNA present in the serum to rapidly bind and hybridize with acpcPNA. Then a fluid containing Au 3+ (which is used for the metallization process) would go through a delayed channel and reach the TL after the DNA hybridization has occurred. Au 3+ binds to hybridized DNA, and after the electrodeposition process, an electrical signal demonstrates HBV DNA detection ( Figure 5A ). The whole detection process takes 7 minutes and has a LOD of 7.23 pM [118] .

J o u r n a l P r e -p r o o f revealed that 1000 copies of HBV DNA could be detected in a 50 μL mixture using this device with a sensitivity and specificity of 90% and 100%, respectively [125] .

An integrated polymerase spiral reaction (PSR) with LFA for sensitive and rapid determination of HBV DNA was developed by Lin and coworkers research group. In this investigation, final products of PSR were labeled with FITC probe and biotin taken to LFA for visualization. STV conjugated Au NPs were used as LFA labeling NPs. Anti-FITC mAb as a capture probe was used at the TL, and biotin-BSA was immobilized at the capture line, and the LFA visualization process takes up to 5 minutes. This sensing platform was examined and showed a specificity of 100%, which is higher than the qPCR and LAMP assay. LOD was measured 5.4 copies/mL that is ten times more sensitive compared with qPCR and LAMP [126] .

LFAs can be more than helpful in developing countries with endemic areas for HBV and lack the expensive conventional devices for HBV detection. Multiplex LFAs are effective in hepatitis viral detection because they also detect various types of hepatitis virus and other sexually transmitted viruses. Integrating LFA with other detection methods, and adjusting the membrane improved sensitivity. These studies also examined alternate readers and reporter probes in quantifying and enhancing detection.

DENV belonging to the family Flaviviridae is transmitted via Aedes mosquitoes . Dengue disease symptoms vary from asymptomatic fever to more severe symptoms like hemorrhagic fever and J o u r n a l P r e -p r o o f shock [127, 128] . Dengue fever is prevalent in 112 countries, around half of the world population is considered at risk and is estimated to have 390 million incidence cases per year [129, 130] .

Dengue fever occurs in underdeveloped urban areas and needs a cheap and portable POCT for diagnosis [130] . Target-specific Ab-conjugated to HRP are present in the conjugation area, and NSP1 molecules are immobilized in the capture area. In negative serums that don't contain NSP1, anti-NSP1-HRPs will be captured by immobilized NSP1 in the capture area, and don't reach the last layer, thus do not generate any signals. However, NSP1 Ags present in positive serums will bind to anti-NSP1-HRPs to form NSP1-specific Ab-HRP immune complex, thus preventing them from being captured by immobilized NSP1s at the capture area, allowing the immune complex to reach the last layer to bind with HRP substrate, generating the signal. This novel LFIA was evaluated and was determined to be five-fold more sensitive than a gold standard ELISA test [134] . Also, Kumar et al. developed an LFA diagnostic test for rapid detection (10 minutes) of DENV NSP1. In this investigation, Au

NPs conjugated with reduced GO (Au NPs-rGO) were used as reporter labels and were conjugated with FITC-NSP1 Abs, increasing the sensitivity and achieving a LOD of 4.9 ng/mL [135] . Tran and coworkers developed a magneto-enzyme LFIA to detect DENV NSP1. In this research, GAM Ab at the CL was used, and at the TL, capture Ab was used. In addition, biotinylated, mAbconjugated magnetic beads were used as reporter probes. This assay was evaluated and reached a sensitivity and specificity of 100%, demonstrating no cross-reaction with other viruses and LOD between 0.1-1 ng/mL applicable for different DENV serotypes [64] . Additionally, a screen-printed gold electrode (SPGE) combination with an LFA strip in the development of an electrochemical lateral flow immunosensor (ELFI), a diagnostic device for DENV was introduced by Sinawang and coworkers. In this device, NSP1 Ab conjugated with immunonanobeads would bind to sample DENV NSP1. The formed immunocomplex would attach with immuno-conjugated electrodes, emitting an electrical signal, allowing a quantitative detection with LOD of 0.5 ng/mL [136] .

In another investigation, a NIR fluorescent dye-based LFA detecting anti-DENV1 IgG Abs by Purra et al. was fabricated. This investigation demonstrates that DYlight-800 coated GAH IgG Abs were used as sample capture, and recombinant protein from envelope of DENV1 at the TL was used. This device was evaluated and compared with DENV Duo IgG/IgM cassette and Panbio DENV IgG ELISA. NIR-LFA reached a sensitivity of 95%, which was the same with compared tests. However, testing diluted serum samples, NIR-LFA had a lower LOD compared with these tests [63] .

Choi et al. combined agarose hydrogel into the glass fiber shunt to develop a paper-hydrogel hybrid LFA test for detecting the DENV. Using this hybrid allows fluid control while maintaining paperbased advantages, increasing Au NP-detector probes (Au NP-DPs) and DENV RNA interaction ( Figure 6B ), thus improving device sensitivity [133] .

An LFA for simultaneous detection of DENV and Chikungunya virus (CHIKV) IgM/IgG using two-color detection labels was established by Lee and coworkers. This study used blue labels for anti-IgG and red labels for anti-IgM for both CHIKV and DENV. Two TLs, one consisting of CHIKV Ag and one consisting of DENV Ag, captured virus-specific Abs, while anti-goat IgG was used to capture all Abs in the CL. Captured Abs in the TLs emitted blue or red lights, resulting in a mixture of blue and red light emitted from the TL of virus, captured and calculated to determine IgG and IgM concentration [137] .

Yrad and coworkers developed an Au NP-based LFA to detect DENV-1 RNA in less than 20 minutes. In this investigation, a capture probe specific to DENV-1 (dDNA) was immobilized at the TL to detect DENV-1 RNA and generates a red light, and a control probe (cDNA) was immobilized at the CL to detect dextrin-capped Au NP. The whole detection process took about 20 minutes, and LOD was calculated to be 1.2 × 10 4 pfu/mL [65] . Xiong and coworkers integrated reverse transcription recombinase-aided amplification with LFA to detect DENV RNA in blood samples.

In this study, primers were designed to detect and amplify DENV RNA and were labeled with FAM and biotin. The amplified nucleic acids were then added to commercially available lateral-J o u r n a l P r e -p r o o f flow dipsticks (USTAR, Hangzhou, China) to determine the results. This approach was evaluated and showed a LOD of 10 copies/μL, with no cross-reactivity with other pathogens [138] .

LFAs can also help detect DENV in underdeveloped areas. These areas also may have high temperatures that need devices that can withstand environmental inconveniences. These studies examined the impact of using alternate readers and reporter probes in quantifying and improving viral detection. Adjusting the membrane also increased the LFA's sensitivity.

HPV belongs to the Papovaviridae family and is a sexually transmitted virus that causes genital warts [139] . Some subtypes such as 16 and 18 showed high risk and may lead to malignancies [140] .

Cervical cancer caused by HPV has a 500,000 incidence rate annually and 250,000 mortalities [141] . Different strategies and approaches are proposed and applied for HPV screening [140] . LFA can be an excellent tool for rapid diagnosis and can be used for screening purposes. For instance, Fluorescent probe-based LFA to detect 13 types of HPV simultaneously have been effectively fabricated by Xu and coworkers. This study explains that primers conjugated with fluorophore were used to amplify HPV nucleic acids, and the final products were added to LFA for detection and discrimination. The LFA reader had two-channel color detection; therefore, each line could be conjugated with two different coloring labels, and the probes on the seven lines each were conjugated with FAM or ROX. The probes were designed to detect 13 types of HPV (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68) and capture probe including human β-globin (HBB) was used as a control probe ( Figure 7A ). The LFA visualization process takes up to 30 minutes. This device was evaluated, and the results showed LODs of 102 copies/μL for HPV type 18 and 10 copies/μL for HPV types 6, 11 and 16. No cross-reactivity was reported, and there was an agreement of 98% with the reverse dot blotting kit (GenoArray) [143] . [144] .

LFAs are rapid devices that can be great for HPV screening. Using multiplex LFA devices is necessary for screening multiple HPV subtypes. Also, using different readers help to quantify the detection.

As a member of the Flaviviridae family, ZKV like DENV is commonly transmitted by mosquitos [145] . ZKV infection causes signs and symptoms like fever, arthralgia and myalgia, conjunctivitis, headache, and rash and may cause Guillain-Barré syndrome [146] . Laboratory tests like serological assays, molecular assays, virus isolation, and IHC can be used to detect ZKV [147] . An integrated RT-LAMP with LFA to develop a device for ZKV detection was reported by Lee et al. ZKV RNAs in this research were amplified with RT-LAMP using primers conjugated with DIG, and the final products were added to LFA for visualization. Au NPs conjugated with STV and anti-DIG were used as reporter probes. Amplified ZKV RNAs contained DIG-conjugated primers and were detected by detector probes and were also captured by immobilized anti-DIGs at the TL. Biotin was also affixed in the CL to bind with STV at the Au NPs [148] .

In another study, Rong et al. established a smartphone-based LFIA to detect NSP1 in ZKV. In this study, QD microspheres were conjugated with ZKV NSP1Ab and BSA to act as reporter probes.

J o u r n a l P r e -p r o o f ZKV NSP1 Ab was also immobilized at the TL to capture detected antigen complex, and GAM IgG pAbs at CL was also used to capture QD microspheres. The captured Ag complex at the TL emitted fluorescent can be detected and interpreted by smartphone and its camera, and the whole detection process takes about 20 minutes. This device was evaluated and showed limited crossreactivity with similarly structured DENV, and LOD in serum was calculated to be 0.15 ng/mL [149] . Schematic illustration for detection of Zika NS1 protein using the iFCS-based LFA (B). Adapted by permission from Ref. [150] . Schematic design of dual-signal readout LFA for EV detection (C). Two-Step

Detection of EBV with RNs@Aubased LFA (D). Adapted by permission from Ref. [68] .

In another study, polycaprolactone (PCL) electron-coating NC membrane to develop a nucleic acid-based LFA for detecting ZKV was introduced by Yew and coworkers. In this study, Au NPs conjugated with detector probes acted as labeled detectors. Electrospun-coated membrane delays the fluid flow and increases interaction between analyte and reagents. Evaluations demonstrated that this device could detect ZKV cDNA with a LOD of 0.5 nM, and its sensitivity is 10-fold higher than unmodified NC membrane-based LFA [151, 152] .

EV belongs to the Filoviridae family and causes a hemorrhagic illness called EV disease transmitted via blood and other body fluids [153] . Its signs and symptoms include fever, chills, malaise, anorexia, severe headache, and myalgia [154] . Many laboratory tests are available for EV detection, but due to its infection nature, POCTs are beneficial for early detection and prevention.

In this way, Hu 

BKV infects humans in early childhood and remains there as an asymptomatic infection, and in appropriate circumstances, like immunosuppression, BKV reactivates and begins its pathogenicity process [158] . BKV infection leads to nephropathy; therefore, it is more common in kidney transplant receivers immunocompromised to avoid graft rejection, so BKV detection is crucial in these patients [159, 160] . In addition to this, CXCL9 messenger RNA, a graft rejection marker, is detected in urine samples.

This device was integrated with a commercially available LFA for detection optimization, and the final products were added to it. The integrated device was evaluated and showed high sensitivity and specificity for BKV, CMV, and CXCL9 messenger RNA detection [161] .

In another study, nucleic acid-based LFA has been established by Huang 

Norovirus belongs to the Caliciviridae family and causes winter vomiting disease [163] . This disease can be asymptomatic or be presented with fever, vomiting, and diarrhea and can be transmitted person-to-person or via food infections [164] . 

A phlebovirus is known to be the cause of SFTS showing symptoms of gastrointestinal disorders, leukocytopenia, and fever [167] . SFTSV belongs to Bunyaviridae family and can be transmitted via ticks [168] . SFTSV can be diagnosed using real-time PCR, ELISA, and virus isolation, and POCT like LFA can be employed for early detection [169] . In Xu et al. investigation, they developed a fluorescence-based LFA to detect SFTSV. In this study, carbon dots/SiO2 nanospheres (CDSNs) were conjugated with anti-SFTSV mAbs to act as reporter probes. Anti-SFTSV Abs were also immobilized at the TL to capture detected Ags, and GAM IgG Abs at the CL were used to capture remaining CDSNs. This device was evaluated, and the SFTSV detection results were consistent with PCR showing no cross-reactivity with HCG, AFP, CEA, CA125 [170] . In another research, Zuo and coworkers developed an LFA using Au NPs conjugated with anti-SFTSV mAbs as reporter probes. These mAbs at the TL were immobilized to CPs, and GAM IgG at the CL was used for capturing Au NPs. This device was evaluated with a LOD of 1 ng/mL, and the whole detection process took up to 10 minutes [71] .

J o u r n a l P r e -p r o o f

LFA-based devices have also been effectively used in the determination of other kinds of viruses.

In an investigation, Li and coworkers constructed an Au NP-based LFA using IgM Abs for detecting four TORCH pathogens including herpes simplex virus type 2 (HSV-2), CMV, rubella virus and toxoplasmosis. In this research, the μ-chain of MAH IgM mAb (anti-human IgM) was conjugated to AuMag to form the reporter probes. TORCH Ags were immobilized at the TL to act as CP, and the GAM IgG Ab at the CL was used as a CP. Serum samples of 162 infected individuals were tested by this device and 100% sensitivity, specificity with no occurrence of cross-reactivity were reported [67] . In another study, Zhu and coworkers developed a fluorescence-based LFA to detect Epstein-Barr virus (EBV) and HPV16. In this study, carboxyl-modified fluorescent microspheres were used as labeling reporters, and NC substrate strips were used as a membrane.

BSA and whole human IgG Ab were used as negative and positive controls, respectively. EBV nuclear Ag-1 (EBVNA-1) was immobilized at the TL to capture EBV Ags. This device was again modified to study anti-HPV 16 E7 IgG detection using recombinant HPB16 E7 proteins. The results showed a 100-fold improvement compared with previous studies that used a glass substrate [171] .

Additionally, HSV-2 is tried to serologically detect by the development of a LFA device in Goux and coworkers research. In this investigation, persistent luminescent NPs (nanophosphors) of strontium aluminate conjugated with GAH pAbs were used as labeling reporters. At the TL, recombinant gG2 Ag of HSV was immobilized to detect anti-HSV Ab, and GAH IgG capture Ab was used at CL to capture the remaining nanophosphors. Nanophosphors at the TL reacted to light and excited, emitting light that can be detected and interpreted by an iPhone app to quantitatively detect anti-HSV Abs captured at the TL [172] .

In an investigation reported by Townsend and coworkers, the authors evaluated commercially available Tetracore Orthopox BioThreat® LFA assay for detecting Orthopoxvirus (OPVs), Vaccinia virus (VACV), and Monkeypox virus (MPXV). In this device, Au NPs conjugated with anti-VACV Abs were used as reporter probes. The anti-VACV Abs were also immobilized at the TL to capture detected OPVs. This assay reached a LOD of 107 pfu/mL and showed a false positive in one out of 11 non-OPV samples; therefore, it is applicable for screening and detecting OPVs [173] . In Rebollo and coworkers study, the authors developed an immune-chromatographic LFA to detect the West Nile virus (WNV). In this study, 1D11 (a mAb that detects WNV's envelope glycoprotein) was conjugated with red carboxyl-latex particles to act as reporter probes, and BSA was conjugated with blue latex particle to serve as a control complex. 1D11 was also immobilized at the TL to capture Ags detected by the detector probe, and the CL consisted of mAbs that captured control-complex proteins. After 10 minutes, in the presence of WNV, a red line is formed at the TL, informing the test positivity. This test was evaluated and successfully detected different WNV strains with LOD of 105 TCID50/mL and showed no cross-reactivity with other flaviviruses [174] .

In recent years, for the effective management of viral diseases, hundreds of POCTs with high sensitivity and specificity have been developed and are commercially available now for detection of most pathogenic viruses such as SARS-Cov-2, HIV, HBV, HCV, Influenza, Ebola, Dengue, HPV, Zika, HCV and etc ( Table 2) . 

This review mainly focused on investigating LFAs in virus detection. Conventional LFAs are rapid, user-friendly, and accessible but certain limitations like low sensitivity and showing the results just by an on/off format constrain them for wide application in virus testing. In addition to these, some LFAs suffer from low reproducibility. The final result and detection time depend on various factors like biomolecule affinity, sample nature, fluid viscosity, and surface tension. The analytes must be in solution form, and samples should be fluid; therefore, pretreatment is required for non-fluidic samples, which is time-consuming. Using gold, silver, and other nanoparticles may limit shelf life and increase test costs [175] . However, many LFAs investigated in this study employed novel methods and strategies to overcome these limitations, but other approaches can further improve LFA performance. Immobilizing Abs on the LFA strip can be organized by passive absorption and covalent coupling; the latter conjugates Abs to carboxyl groups on functionalized nanoparticles that improve performance. The LFA strip membrane can also be adjusted to delay fluid flow and increase reagents interactions to ensure that reagents binding is optimal, increase sensitivity and reduce detection time. Using dissolvable barriers between the conjugate pad and test line and between test line and control line has been proven effective in increasing LFA's sensitivity [176, 177] . Integrating LFA with other methods can significantly increase its sensitivity. Many techniques like LAMP, PCR, CRISPR-Cas13a, RT-RPA, etc., were used to amplify virus nucleic acids and employed LFA for visualization. With the recent advancements in nanomaterials, many approaches have been suggested to improve LFAs. Two sets of GNPs with two different sizes can be used as reporter probes, as the GNPs with smaller sizes bind to the analytes, and the GNPs with bigger sizes bind to the first group of GNPs. [178] Using alternate labeling reporters, like magnetic particles, quantum dots, upconverting phosphors, europium, latex beads, enzymes, and colloidal carbons could also enhance the signal and increase LFA's sensitivity. Several undesirable interface J o u r n a l P r e -p r o o f issues can occur in developing LFAs at molecular levels like in NP-antibody conjugates, immobilized antibodies, and Antibody-biomarker interactions, and with the advancements in nanotechnology, resolving these interface issues can be the next breakthrough in LFA design [179] .

Also, the employment of alternative reporters allows novel visualization methods that can be digitized and allows quantitative detection. Visual detection, luminescence detection, magnetic detection, SERS detection, electrochemical detection was used in LFAs, each having its advantages and disadvantages. Quantitative detection can also be obtained using image analysis software that calculated the virus concentration by interpreting the line intensity at the TL. Multiplex detection was also used at these LFAs, some detecting 13 different Ags simultaneously, which can help confirm the differential diagnosis in infectious diseases with similar signs and symptoms.

Subsequently, LFAs can be widely used in clinical settings and replace expensive and timeconsuming methods with these moderations. Finally, this review finds that LFAs as one of the effective alternative methods in virus detection, mainly due to their rapidity and portability. By further improvements, they can be commonly used in clinical diagnosis.

The authors have no conflict of interest to declare.

Viruses: Definition, Structure, Classification, Molecular Virology

What Is a Virus?

Medical Importance of Viruses

Virus Transmission and Epidemiology, Essential Human Virology

Human viruses: discovery and emergence

Transmissibility of emerging viral zoonoses

Viral Pathogenesis

The importance of specific virus diagnosis and monitoring for antiviral treatment

Recent advances in lab-on-a-chip technologies for viral diagnosis

Immunosensing of breast cancer prognostic marker in adenocarcinoma cell lysates and unprocessed human plasma samples using gold nanostructure coated on organic substrate

Proline dehydrogenase-entrapped mesoporous magnetic silica nanomaterial for electrochemical biosensing of Lproline in biological fluids

Recent advances in the highly sensitive determination of zearalenone residues in water and environmental resources with electrochemical biosensors

Poly-dopaminebeta-cyclodextrin: A novel nanobiopolymer towards sensing of some amino acids at physiological pH

HIV biosensors for early diagnosis of infection: The intertwine of nanotechnology with sensing strategies

Bimetallic Fe/Mn MOFs/MβCD/AuNPs stabilized on MWCNTs for developing a label-free DNA-based genosensing bioassay applied in the determination of Salmonella typhimurium in milk samples

Layer double hydroxides (LDHs)-based electrochemical and optical sensing assessments for quantification and identification of heavy metals in water and environment samples: A review of status and prospects

Ten Years of Lateral Flow Immunoassay Technique Applications: Trends, Challenges and Future Perspectives

Evolution in Lateral Flow-Based Immunoassay Systems

Immunological Techniques: ELISA, Flow Cytometry, and Immunohistochemistry

Viral Detection: Past, Present, and Future

Diagnostic Techniques: Serological and Molecular Approaches, Encyclopedia of Virology

A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA

Enzyme Linked Immunosorbeny assay, StatPearls, StatPearls

Validation of serological and molecular methods for diagnosis of zika virus infections

Serologic Testing for Zika Virus: Comparison of Three Zika Virus IgM-Screening Enzyme-Linked Immunosorbent Assays and Initial Laboratory Experiences

Evaluation of Euroimmun Anti-Zika Virus IgM and IgG Enzyme-Linked Immunosorbent Assays for Zika Virus Serologic Testing

Lion, Detection and monitoring of virus infections by real-time PCR

Comparison of Four Serological Methods and Two Reverse Transcription-PCR Assays for Diagnosis and Surveillance of Zika Virus Infection

Performance of the Trioplex real-time RT-PCR assay for detection of Zika, dengue, and chikungunya viruses

Seroprevalence of Anti-SARS-CoV-2 Antibodies in

Loopmediated isothermal amplification of DNA

Colorimetric loop-mediated isothermal amplification (LAMP) for cost-effective and quantitative detection of SARS-CoV-2: the change in color in LAMP-based assays quantitatively correlates with viral copy number

On-chip LAMP-BART reaction for viral DNA realtime bioluminescence detection

Rapid and simple colorimetric detection of multiple influenza viruses infecting humans using a reverse transcriptional loopmediated isothermal amplification (RT-LAMP) diagnostic platform

Current methods for diagnosis of human coronaviruses: pros and cons

Benefits and limitations of serological assays in COVID-19 infection

Lateral flow assays

Lateral flow assays

Recent advancements in structural improvements of lateral flow assays towards point-of-care testing

Enhancing sensitivity of lateral flow assay with application to SARS-CoV-2

Lateral flow assays towards point-of-care cancer detection: A review of current progress and future trends

Designs, formats and applications of lateral flow assay: A literature review

State of the art: Lateral flow assay (LFA) biosensor for on-site rapid detection

Improvement in Detection Limit for Lateral Flow Assay of Biomacromolecules by Test-Zone Pre-enrichment

The SARS-COV-2 Spike Protein Binds Sialic Acids and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device

Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal Gold Nanoparticle-Based Lateral-Flow Assay

Rapid One-Pot Detection of SARS-CoV-2 Based on a Lateral Flow Assay in Clinical Samples

Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins

A multi-target lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2

Dual lateral flow optical/chemiluminescence immunosensors for the rapid detection of salivary and serum IgA in patients with COVID-19 disease

Development of a lateral flow immunoassay strip for rapid detection of IgG antibody against SARS-CoV-2 virus

Point-of-care test system for detection of immunoglobulin-G and -M against nucleocapsid protein and spike glycoprotein of SARS-CoV-2

Combination of the NanoSuit method and gold/platinum particle-based lateral flow assay for quantitative and highly sensitive diagnosis using a desktop scanning electron microscope

Rapid and background-free detection of avian influenza virus in opaque sample using NIR-to-NIR upconversion nanoparticle-based lateral flow immunoassay platform

Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C, Annals of laboratory medicine

Evaluation of high-throughput digital lateral flow immunoassays for the detection of influenza A/B viruses from clinical swab samples

Multiplex diagnosis of viral infectious diseases (AIDS, hepatitis C, and hepatitis A) based on point of care lateral flow assay using engineered proteinticles

A SERS-based lateral flow assay biosensor for highly sensitive detection of HIV-1 DNA

Applying strand displacement amplification to quantum dots-based fluorescent lateral flow assay strips for HIV-DNA detection

Integrated fluorescent lateral flow assay platform for point-of-care diagnosis of infectious diseases by using a multichannel test cartridge

Ultrasensitive paper based nucleic acid detection realized by three-dimensional DNA-AuNPs network amplification

Upconverting nanoparticle reporter-based highly sensitive rapid lateral flow immunoassay for hepatitis B virus surface antigen

A rapid point-of-care test for dengue virus-1 based on a lateral flow assay with a near-infrared fluorescent dye

Development of a highly sensitive magneto-enzyme lateral flow immunoassay for dengue NS1 detection

Visual Detection of Dengue-1 RNA Using Gold Nanoparticle-Based Lateral Flow Biosensor

Antarctic thermolabile uracil-DNA-glycosylasesupplemented multiple cross displacement amplification using a label-based nanoparticle lateral flow biosensor for the simultaneous detection of nucleic acid sequences and elimination of carryover contamination

A multifunctional hemin@ metal-organic framework and its application to construct an electrochemical aptasensor for thrombin detection

Dual-Signal Readout Nanospheres for Rapid Point-of-Care Detection of Ebola Virus Glycoprotein

Characterization and analytical validation of a new antigenic rapid diagnostic test for Ebola virus disease detection

Development of an antigen detection assay for early point-of-care diagnosis of Zaire ebolavirus

Rapid Detection of Severe Fever with Thrombocytopenia Syndrome Virus via Colloidal Gold Immunochromatography Assay

The SARS-CoV-2 outbreak: What we know

Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials

An overview on SARS-CoV-2 (COVID-19) and other human coronaviruses and their detection capability via amplification assay, chemical sensing, biosensing, immunosensing, and clinical assays

Laboratory testing of SARS-CoV, MERS-CoV, and SARS-CoV-2 (2019-nCoV): Current status, challenges, and countermeasures

Two serological approaches for detection of antibodies to SARS-CoV-2 in different scenarios: a screening tool and a point-of-care test

Rapid point-of-care testing for SARS-CoV-2 virus nucleic acid detection by an isothermal and nonenzymatic Signal amplification system coupled with a lateral flow immunoassay strip

SARS-CoV-2 Coronavirus Nucleocapsid Antigen-Detecting Half-Strip Lateral Flow Assay Toward the Development of Point of Care Tests Using Commercially Available Reagents

Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay

Higher Sensitivity Provided by the Combination of Two Lateral Flow Immunoassay Tests for the Detection of COVID-19 Immunoglobulins

A Saliva-Based RNA Extraction-Free Workflow Integrated With Cas13a for SARS-CoV-2 Detection

Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama

Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG™ lateral flow assay

Rapid Detection of 2019 Novel Coronavirus SARS-CoV-2 Using a CRISPR-based DETECTR Lateral Flow Assay, medRxiv : the preprint server for health sciences

Enhancing sensitivity of lateral flow assay with application to SARS-CoV-2

Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients, Clinical microbiology and infection : the official publication of the

Simultaneous Dual-Gene Diagnosis of SARS-CoV-2 Based on CRISPR/Cas9-Mediated Lateral Flow Assay

Recent advances in sensitive surface-enhanced Raman scattering-based lateral flow assay platforms for point-ofcare diagnostics of infectious diseases

A Narrative Review of Influenza: A Seasonal and Pandemic Disease

Detection Methods of Human and Animal Influenza Virus-Current Trends

Recent trends in rapid detection of influenza infections by bio and nanobiosensor

Dual Recognition Element Lateral Flow Assay Toward Multiplex Strain Specific Influenza Virus Detection

Specific detection of avian influenza H5N2 whole virus particles on lateral flow strips using a pair of sandwich-type aptamers

Magnetic SERS Strip for Sensitive and Simultaneous Detection of Respiratory Viruses

Specific Detection of Influenza A and B Viruses by CRISPR-Cas12a-Based Assay

Rapid Detection of Avian Influenza A Virus (H7N9) by Lateral Flow Dipstick Recombinase Polymerase Amplification

Rapid Enrichment and Ultrasensitive Detection of Influenza A Virus in Human Specimen using Magnetic Quantum Dot Nanobeads Based Test Strips

Sensitivity enhancement of lateral flow assay by embedding cotton threads in paper

Visual signal generation for the detection of influenza viruses by duplex recombinase polymerase amplification with lateral flow dipsticks

Rapid and Ultrasensitive Quantification of Multiplex Respiratory Tract Infection Pathogen via Lateral Flow Microarray based on SERS Nanotags

Carbon nanotag based visual detection of influenza A virus by a lateral flow immunoassay

Emerging concepts in the immunopathogenesis of AIDS

Late presentation of HIV infection: a consensus definition

Rapid detection of HIV-1 proviral DNA for early infant diagnosis using recombinase polymerase amplification

Improved sensitivity of lateral flow assay using paper-based sample concentration technique

Switching from Multiplex to Multimodal Colorimetric Lateral Flow Immunosensor

Rapid detection and differentiation of antibodies to HIV-1 and HIV-2 using multivalent antigens and magnetic immunochromatography testing

Development of a novel rapid HIV test for simultaneous detection of recent or long-term HIV type 1 infection using a single testing device

A lateral flow assay for quantitative detection of amplified HIV-1 RNA

Double-Antigen Lateral Flow Immunoassay for the Detection of Anti-HIV-1 and -2 Antibodies Using Upconverting Nanoparticle Reporters

Dual rapid lateral flow immunoassay fingerstick wholeblood testing for syphilis and HIV infections is acceptable and accurate

Development and optimization of thermal contrast amplification lateral flow immunoassays for ultrasensitive HIV p24 protein detection

A New Method for Ultra-sensitive P24 Antigen Assay Based on Near-infrared Fluorescent Microsphere Immunochromatography

Clinical virology of hepatitis B virus infection

Diagnosis of hepatitis via nanomaterial-based electrochemical, optical or piezoelectrical biosensors: a review on recent advancements

Hepatitis B Virus Infection: What Is Current and New

Hepatitis B: the virus and disease

Amplificationfree DNA Sensor for the One-Step Detection of the Hepatitis B Virus Using an Automated Paper-Based Lateral Flow Electrochemical Device

A PDMS-Paper Hybrid Lateral Flow Assay for Highly Sensitive Point-of-Care Nucleic Acid Testing

Improved Analytical Sensitivity of Lateral Flow Assay using Sponge for HBV Nucleic Acid Detection, Sci Rep

Development of Lateral Flow Assay Based on Size-Controlled Gold Nanoparticles for Detection of Hepatitis B Surface Antigen

A portable and universal upconversion nanoparticle-based lateral flow assay platform for point-of-care testing

Development of up-converting phosphor technology-based lateral-flow assay for rapidly quantitative detection of hepatitis B surface antibody, Diagnostic microbiology and infectious disease

A signal amplification system on a lateral flow immunoassay detecting for hepatitis e-antigen in human blood samples

Betaine-assisted recombinase polymerase assay for rapid hepatitis B virus detection

Rapid Detection of Hepatitis B Virus in Blood Samples Using a Combination of Polymerase Spiral Reaction With Nanoparticles Lateral-Flow Biosensor

Dengue Fever: Causes, Complications, and Vaccine Strategies

Dengue virus: a review on advances in detection and trends-from conventional methods to novel biosensors

Dengue viral infections

Dengue: a growing threat requiring vaccine development for disease prevention

Improvement of reproducibility and thermal stability of surface-enhanced Raman scattering-based lateral flow assay strips using silica-encapsulated gold nanoparticles

Surface-Enhanced Raman Spectroscopy-Based Sandwich Immunoassays for Multiplexed Detection of Zika and Dengue Viral Biomarkers

Lateral Flow Assay Based on Paper-Hydrogel Hybrid Material for Sensitive Point-of-Care Detection of Dengue Virus

Capture-Layer Lateral Flow Immunoassay: A New Platform Validated in the Detection and Quantification of Dengue NS1

Tapered lateral flow immunoassay based pointof-care diagnostic device for ultrasensitive colorimetric detection of dengue NS1

Electrochemical lateral flow immunosensor for detection and quantification of dengue NS1 protein

Two-Color Lateral Flow Assay for Multiplex Detection of Causative Agents Behind Acute Febrile Illnesses

Rapid visual detection of dengue virus by combining reverse transcription recombinase-aided amplification with lateral-flow dipstick assay

Human Polyomaviruses and Papillomaviruses

Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives

HPV-Related Disease, and the HPV Vaccine

A paper-based immunoassay to determine HPV vaccination status at the point-of-care

Fluorescent probe-based lateral flow assay for multiplex nucleic acid detection

Development of a lateral flow strip biosensor based on copper oxide nanoparticles for rapid and sensitive detection of HPV16 DNA

A review on Zika virus outbreak, epidemiology, transmission and infection dynamics

The emergence of Zika virus and its new clinical syndromes

Zika Virus Infection, Basic and Clinical Aspects: A Review Article

Simple and Highly Sensitive Molecular Diagnosis of Zika Virus by Lateral Flow Assays

Smartphone-based fluorescent lateral flow immunoassay platform for highly sensitive point-of-care detection of Zika virus nonstructural protein 1

Luminous silica colloids with carbon dot incorporation for sensitive immunochromatographic assay of Zika virus

Electrospin-coating of nitrocellulose membrane enhances sensitivity in nucleic acid-based lateral flow assay

Electrospun Polycaprolactone Nanofibers as a Reaction Membrane for Lateral Flow Assay

Ebola virus: A global public health menace: A narrative review

Ebola Virus Disease: Focus on Children

A Serological Point-of-Care Test for the Detection of IgG Antibodies against Ebola Virus in Human Survivors

The Use of Near-Infrared Light-Emitting Fluorescent Nanodiamond Particles to Detect Ebola Virus Glycoprotein: Technology Development and Proof of Principle

Lateral Flow Immunoassays for Ebola Virus Disease Detection in Liberia

Advances in BK Virus Complications in Organ Transplantation and Beyond

Management of BK-virus infection -Swedish recommendations

BK Virus Nephropathy and Kidney Transplantation

A CRISPR-based assay for the detection of opportunistic infections post-transplantation and for the monitoring of transplant rejection

Development of a Nucleic Acid Lateral Flow Immunoassay for the Detection of Human Polyomavirus BK

Human norovirus transmission and evolution in a changing world

Sensitive detection of norovirus using phage nanoparticle reporters in lateral-flow assay

Development of a Nanobody-Based Lateral Flow Immunoassay for Detection of Human Norovirus, mSphere

Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy

The severe fever with thrombocytopenia syndrome bunyavirus (SFTSV) antibody in a highly endemic region from 2011 to 2013: a comparative serological study

Diagnostic system for the detection of severe fever with thrombocytopenia syndrome virus RNA from suspected infected animals

Ultrasensitive Detection of Severe Fever with Thrombocytopenia Syndrome Virus Based on Immunofluorescent Carbon Dots/SiO(2) Nanosphere-Based Lateral Flow Assay

Highly sensitive fluorescence-based lateral flow platform for point-of-care detection of biomarkers in plasma

Evaluation of a nanophosphor lateral-flow assay for self-testing for herpes simplex virus type 2 seropositivity

Evaluation of the Tetracore Orthopox BioThreat® antigen detection assay using laboratory grown orthopoxviruses and rash illness clinical specimens

A monoclonal antibody to DIII E protein allowing the differentiation of West Nile virus from other flaviviruses by a lateral flow assay

Six decades of lateral flow immunoassay: from determining metabolic markers to diagnosing COVID-19

Dissolvable sugar barriers to enhance the sensitivity of nitrocellulose membrane lateral flow assay for COVID-19 nucleic acid

Improving the sensitivity of cellulose fiber-based lateral flow assay by incorporating a water-dissolvable polyvinyl alcohol dam

Integrated Nanomaterials and Nanotechnologies in Lateral Flow Tests for Personalized Medicine Applications

We acknowledge the supports from the Immunology Research Center, Tabriz University of Medical Science.J o u r n a l P r e -p r o o f